RNF126 Glue Degrades a Cancer Associated GPCR in Cells

Company Hebrew University of Jerusalem (Kashkush and colleagues) Event Type Peer-reviewed publication Modality Covalent molecular-glue degrader (RNF126-recruiting) Asset MG-CB2 Target Cannabinoid receptor 1 (CB1R) Disease Area Cancer (breast and liver cell models) Summary An online-first, peer-reviewed npj Drug Discovery study dated 26 October reports covalent…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *